Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of the LUM Imaging System for in Vivo and Ex Vivo Detection of Cancer in Subjects with Low Grade Gliomas, Glioblastomas, and Cancer Metastases to the Brain

NCT03717142 is registered in ClinicalTrials.gov with Lumicell, Inc. as lead sponsor.

NCT NCT03717142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03717142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of the LUM Imaging System for in Vivo and Ex Vivo Detection of Cancer in Subjects with Low Grade Gliomas, Glioblastomas, and Cancer Metastases to the Brain
Lead sponsor
Lumicell, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
May 3, 2019
Completion date
June 14, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, low grade glioma of brain, metastasis to brain